» Articles » PMID: 25915842

Sirtuin 3 Inhibits Hepatocellular Carcinoma Growth Through the Glycogen Synthase Kinase-3β/BCL2-associated X Protein-dependent Apoptotic Pathway

Overview
Journal Oncogene
Date 2015 Apr 28
PMID 25915842
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

SIRT3 is a class III histone deacetylase that has been implicated in a variety of cancers. The role of SIRT3 in hepatocellular carcinoma (HCC) remains elusive. In this study, we found that SIRT3 expression was frequently repressed in HCC and its downregulation was closely associated with tumor grade and size. Ectopic expression of SIRT3 inhibited cell growth and induced apoptosis in HCC cells, whereas depletion of SIRT3 in immortalized hepatocyte promoted cell growth and decreased epirubicin-induced apoptosis. Mechanistic studies revealed that SIRT3 deacetylated and activated glycogen synthase kinase-3β (GSK-3β), which subsequently induced expression and mitochondrial translocation of the pro-apoptotic protein BCL2-associated X protein (Bax) to promote apoptosis. GSK-3β inhibitor or gene silencing of BAX reversed SIRT3-induced growth inhibition and apoptosis. Furthermore, SIRT3 overexpression also suppressed tumor growth in vivo. Together, this study reveals a role of SIRT3/GSK-3β/Bax signaling pathway in the suppression of HCC growth, and also suggests that targeting this pathway may represent a potential therapeutic approach for HCC treatment.

Citing Articles

The role of acetylation and deacetylation in cancer metabolism.

Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.

PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.


Targeting sirtuins for cancer therapy: epigenetics modifications and beyond.

Shen H, Qi X, Hu Y, Wang Y, Zhang J, Liu Z Theranostics. 2024; 14(17):6726-6767.

PMID: 39479446 PMC: 11519805. DOI: 10.7150/thno.100667.


Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction.

Lu Y, Li Y, Xie Y, Bu J, Yuan R, Zhang X Int J Mol Sci. 2024; 25(14).

PMID: 39062982 PMC: 11277469. DOI: 10.3390/ijms25147740.


Sirtuin insights: bridging the gap between cellular processes and therapeutic applications.

Kamal S, Babar S, Ali W, Rehman K, Hussain A, Akash M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):9315-9344.

PMID: 38976046 DOI: 10.1007/s00210-024-03263-9.


The dual role of sirtuins in cancer: biological functions and implications.

Yu L, Li Y, Song S, Zhang Y, Wang Y, Wang H Front Oncol. 2024; 14:1384928.

PMID: 38947884 PMC: 11211395. DOI: 10.3389/fonc.2024.1384928.


References
1.
Allison S, Milner J . SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle. 2007; 6(21):2669-77. DOI: 10.4161/cc.6.21.4866. View

2.
Michan S, Sinclair D . Sirtuins in mammals: insights into their biological function. Biochem J. 2007; 404(1):1-13. PMC: 2753453. DOI: 10.1042/BJ20070140. View

3.
Hori Y, Kuno A, Hosoda R, Horio Y . Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One. 2013; 8(9):e73875. PMC: 3770600. DOI: 10.1371/journal.pone.0073875. View

4.
Cheng Y, Ren X, Gowda A, Shan Y, Zhang L, Yuan Y . Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. Cell Death Dis. 2013; 4:e731. PMC: 3730425. DOI: 10.1038/cddis.2013.254. View

5.
Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A . SIRT6 promotes DNA repair under stress by activating PARP1. Science. 2011; 332(6036):1443-6. PMC: 5472447. DOI: 10.1126/science.1202723. View